Retractable Technologies Profit Margin 2006-2018 | RVP

Current and historical gross, operating and net profit margin for Retractable Technologies (RVP) over the last 10 years. The current net profit margin for Retractable Technologies as of June 30, 2018 is -6.63%.
Retractable Technologies Annual Profit Margin Summary
Retractable Technologies Quarterly Profit Margin Summary
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $0.024B $0.034B
Retractable Technologies, Inc. designs, develops, manufactures, and markets innovative patented safety needle devices for the healthcare industry.
Stock Name Country Market Cap PE Ratio
Becton, Dickinson (BDX) United States $67.726B 24.25
Align Technology (ALGN) United States $28.698B 76.51
McKesson (MCK) United States $25.846B 9.89
AmerisourceBergen (ABC) United States $18.979B 13.79
Laboratory Of America Holdings (LH) United States $18.565B 17.07
Cardinal Health (CAH) United States $16.125B 10.81
Cooper (COO) United States $12.651B 23.55
Henry Schein (HSIC) United States $12.301B 20.98
DENTSPLY SIRONA (XRAY) United States $8.598B 15.05
West Pharmaceutical Services (WST) United States $8.532B 44.11
Merit Medical Systems (MMSI) United States $3.101B 40.76
Patterson (PDCO) United States $2.237B 14.01
CONMED (CNMD) United States $2.185B 37.00
STAAR Surgical (STAA) United States $1.804B 241.47
Atrion (ATRI) United States $1.213B 35.96
Antares Pharma (ATRS) United States $0.534B 0.00
Invacare (IVC) United States $0.525B 0.00
Endologix (ELGX) United States $0.215B 0.00
Lifevantage (LFVN) United States $0.163B 23.08
Aceto (ACET) United States $0.100B 4.07
Biolase (BIOL) United States $0.037B 0.00
Pro-Dex (PDEX) United States $0.029B 12.69
Milestone Scientific (MLSS) United States $0.025B 0.00